Medicare paid 50% more for neurology drugs over 5 years while claims rose only 8%
Sharp reductions in costs of producing cannabis, fentanyl likely to spur widespread changes in use, dependence
10 March 2021Recuperation unit decreased hospitalizations of homeless individuals with COVID-19
10 March 2021Medicare paid 50% more for neurology drugs over 5 years while claims rose only 8%
A new study of Medicare payments has found that over a five-year period, the payments for medications prescribed to people with neurologic conditions like multiple sclerosis (MS), Parkinson’s disease and epilepsy increased by 50% while the number of claims for these prescription medications only rose by only 8%. The study is published in the March 10, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology. The study, funded by the American Academy of Neurology, also found that most of the increase was due to rising costs for neuroimmunology drugs, mostly for multiple sclerosis.
